Progenics Pharmaceuticals Has Returned 28.1% Since SmarTrend Recommendation (PGNX)
May 23, 2017 at 02:12 AM EDT
SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on March 30th, 2017 at $9.67. In approximately 2 months, Progenics Pharmaceuticals has returned 28.09% as of today's recent price of...
